Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
暂无分享,去创建一个
B N Bundy | W. Sause | B. Bundy | S. Liao | D. Clarke‐Pearson | E V Hannigan | W. Fowler | C. Whitney | E. Hannigan | D L Clarke-Pearson | W C Fowler | C W Whitney | W Sause | J H Malfetano | S Y Liao | J. Malfetano | C. Whitney
[1] J. Blessing,et al. Hydroxy urea and radiation for stages IIIB and IVA cervix cancer analysis of recurrence patterns and radiation factors , 1980 .
[2] Straus Mj,et al. Synchronization of L1210 leukemia with hydroxyurea infusion and the effect of subsequent pulse dose chemotherapy. , 1980 .
[3] H. Bartelink,et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. , 1992, The New England journal of medicine.
[4] E. Vokes. Combined-modality therapy of head and neck cancer. , 1997, Oncology.
[5] C. Catton,et al. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. , 1991, International journal of radiation oncology, biology, physics.
[6] M. Gamerre,et al. Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma. , 1994, Gynecologic oncology.
[7] S. Okkan,et al. A randomised study of ornidazole as a radiosensitiser in carcinoma of the cervix: long term results. , 1996, The British journal of cancer. Supplement.
[8] C. Drescher,et al. Continuous infusion of low-dose 5-fluorouracil and radiation therapy for poor-prognosis squamous cell carcinoma of the uterine cervix. , 1992, Gynecologic oncology.
[9] B. Bundy,et al. A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix. A preliminary report of a Gynecologic Oncology Group study. , 1988, American journal of obstetrics and gynecology.
[10] G. Fletcher,et al. Analysis of sites and causes of failures of irradiation in invasive squamous cell carcinoma of the intact uterine cervix. , 1975, Radiology.
[11] B. Bundy,et al. Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] L. Blumenson,et al. Hydroxyurea: a radiation potentiator in carcinoma of the uterine cervix. A randomized double-blind study. , 1983, American journal of obstetrics and gynecology.
[13] N. Mantel. Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.
[14] V. Gebski,et al. Concurrent 5-fluorouracil, mitomycin C and irradiation in locally advanced cervix cancer. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[15] S. Chen,et al. Effective multimodality treatment for advanced epidermoid carcinoma of the female genital tract. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] L. Coia,et al. The patterns of care outcome study for cancer of the uterine cervix results of the second national practice survey , 1990, Cancer.
[17] V. Vaitkevicius,et al. Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion. , 1980, Cancer research.
[18] K. K. Lan,et al. Stochastically curtailed tests in long–term clinical trials , 1982 .
[19] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[20] S. Crooke,et al. Cisplatin : current status and new developments , 1980 .
[21] H. Keys,et al. Aggressive multimodality treatment for cervical cancer with paraaortic lymph node metastases. , 1991, Gynecologic oncology.
[22] J. Cooper,et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. , 1992, The New England journal of medicine.
[23] J. Cooper,et al. Preliminary results of concurrent radiotherapy and chemotherapy in advanced cervical carcinoma: a phase I-II prospective intergroup NCOG-RTOG Study. , 1990, Gynecologic oncology.
[24] M. Brundage,et al. Phase II study to evaluate the toxicity and efficacy of concurrent cisplatin and radiation therapy in the treatment of patients with locally advanced squamous cell carcinoma of the cervix. , 1995, Gynecologic oncology.
[25] D. Decker,et al. Chemotherapy of carcinoma of the cervix. , 1977, Gynecologic oncology.
[26] P. Disaia,et al. A phase II evaluation of cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. , 1989, Gynecologic oncology.
[27] G. Khoury,et al. Concomitant pelvic irradiation, 5-fluorouracil and mitomycin C in the treatment of advanced cervical carcinoma. , 1991, The British journal of radiology.
[28] P. Disaia,et al. Carcinoma of the cervix treated with radiation therapy I. A multi‐variate analysis of prognostic variables in the gynecologic oncology group , 1991, Cancer.
[29] H. B. Mann,et al. On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other , 1947 .
[30] M. Bowen,et al. A feasibility study of 252Cf neutron brachytherapy, cisplatin + 5-FU chemo-adjuvant and accelerated hyperfractionated radiotherapy for advanced cervical cancer. , 1994, International journal of radiation oncology, biology, physics.
[31] A. Fyles,et al. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer. , 1998, Gynecologic oncology.
[32] S. Formenti,et al. Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot study. , 1997, Gynecologic oncology.
[33] L. Twiggs,et al. Concurrent weekly cis-platinum and radiotherapy in advanced cervical cancer: a preliminary dose escalating toxicity study. , 1986, Gynecologic oncology.
[34] T. Phillips,et al. Final report on the united states phase i clinical trial of the hypoxic cell radiosensitizer, misonidazole (RO‐07‐0582; NSC #261037) , 1981, Cancer.
[35] H. Greenberg,et al. Further experience with radiation therapy and concomitant intravenous chemotherapy in advanced carcinoma of the lower female genital tract. , 1991, Gynecologic oncology.
[36] L. Blumenson,et al. Hydroxyurea as a radiation sensitizer in women with carcinoma of the uterine cervix. , 1977, American journal of obstetrics and gynecology.
[37] D. Choy,et al. Long-term follow-up of potentiation of radiotherapy by cis-platinum in advanced cervical cancer. , 1989, Gynecologic oncology.
[38] P. Disaia,et al. Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] C. Perez. Radiation therapy in the management of cancer of the cervix. , 1993, Oncology.
[40] P. Nguyen,et al. Mitomycin-C/5-FU and radiation therapy for locally advanced uterine cervical cancer. , 1991, Gynecologic Oncology.
[41] B. Clark,et al. Weekly cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix. , 1993, International journal of radiation oncology, biology, physics.
[42] B. Chabner. Pharmacologic principles of cancer treatment , 1982 .
[43] E. Douple,et al. Radiosensitization of hypoxic tumor cells by cis- and trans-dichlorodiammineplatinum (II). , 1979, International journal of radiation oncology, biology, physics.
[44] J. Purdy,et al. Radiation therapy alone in the treatment of carcinoma of uterine cervix I. Analysis of tumor recurrence , 1983, Cancer.
[45] P. Grigsby,et al. Phase I/II Study of Definitive Radiotherapy and Chemotherapy (Cisplatin and 5‐Fluorouracil) for Advanced or Recurrent Gynecologic Malignancies: Preliminary Report , 1989, American journal of clinical oncology.
[46] David R. Cox,et al. Regression models and life tables (with discussion , 1972 .
[47] C. Runowicz,et al. Concomitant cisplatin and radiotherapy in locally advanced cervical carcinoma. , 1989, Gynecologic oncology.
[48] L. Tolmach,et al. Repair of potentially lethal damage in x-irradiated HeLa cells. , 1966, Radiation research.
[49] T. Choy,et al. Potentiation of radiotherapy by cis-dichlorodiammine platinum (II) in advanced cervical carcinoma. , 1986, Gynecologic oncology.
[50] P. Taylor,et al. A phase I‐II trial of multimodality management of bulky gynecologic malignancy: Combined chemoradiosensitization and radiotherapy , 1990, Cancer.
[51] W. K. Sinclair. Hydroxyurea: Differential Lethal Effects on Cultured Mammalian Cells during the Cell Cycle , 1965, Science.
[52] C. Coleman,et al. Hypoxic cell radiosensitizers: expectations and progress in drug development. , 1985, International journal of radiation oncology, biology, physics.
[53] C. Hudson,et al. Synchronous 5-fluorouracil, mitomycin-C and radiation therapy in the treatment of locally advanced carcinoma of the cervix. , 1988, International journal of radiation oncology, biology, physics.
[54] Y. Soong,et al. A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix. , 1997, Gynecologic oncology.
[55] K. Fu. Biological basis for the interaction of chemotherapeutic agents and radiation therapy , 1985, Cancer.
[56] A. Einstein,et al. Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. , 1987, JAMA.
[57] J. Cooper,et al. Radiotherapy with or without misonidazole for patients with stage IIIB or stage IVA squamous cell carcinoma of the uterine cervix: preliminary report of a Radiation Therapy Oncology Group randomized trial. , 1987, International journal of radiation oncology, biology, physics.
[58] J. Jan,et al. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix. , 1996, Gynecologic oncology.
[59] D. Schoenfeld,et al. Sample-size formula for the proportional-hazards regression model. , 1983, Biometrics.
[60] H. Shingleton,et al. Hydroxyurea or placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis. , 1979, International journal of radiation oncology, biology, physics.
[61] Anna M. Miller,et al. Treatment of 29 patients with bulky squamous cell carcinoma of the cervix with simultaneous cisplatin, 5-fluorouracil, and split-course hyperfractionated radiation therapy☆ , 1990 .
[62] P. Verrelle,et al. Curability of mouse L1210 leukemia by combination of 5-fluorouracil, cis-diamminedichloroplatinum(II), and low doses of gamma-rays. , 1984, Cancer research.
[63] I. Han,et al. High-dose-rate afterloading brachytherapy, external radiation therapy, and combination chemotherapy in poor-prognosis cancer of the cervix , 1991 .